دورية أكاديمية

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial

التفاصيل البيبلوغرافية
العنوان: Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
المؤلفون: Zamagni, Elena, Oliva, Stefania, Gay, Francesca, Capra, Andrea, Rota-Scalabrini, Delia, D'Agostino, Mattia, Belotti, Angelo, Galli, Monica, Racca, Manuela, Zambello, Renato, Gamberi, Barbara, Albano, Domenico, Bertamini, Luca, Versari, Annibale, Grasso, Mariella, Sgherza, Nicola, Priola, Claudia, Fioritoni, Francesca, Patriarca, Francesca, De Cicco, Gabriella, Villanova, Tania, Pascarella, Anna, Zucchetta, Pietro, Tacchetti, Paola, Fanti, Stefano, Mancuso, Katia, Barbato, Simona, Boccadoro, Mario, Musto, Pellegrino, Cavo, Michele, Nanni, Cristina
المصدر: In eClinicalMedicine June 2023 60
قاعدة البيانات: ScienceDirect
الوصف
تدمد:25895370
DOI:10.1016/j.eclinm.2023.102017